agriculture
U.S. FDA issues four observations to Gland Pharma formulation facility near Hyderabad
Confidence88·multiple reportsImportance90NP-EVT-20261024-2B06B56
The four Form 483 observations followed an unannounced inspection on current good manufacturing practice at the facility in Dundigal between October 12 and 23
Read the original at the primary source
U.S. FDA issues four observations to Gland Pharma formulation facility near Hyderabad
10/24/2026, 5:38:23 AM
Also on the network: airlinesairports · farmerspulse · foodpulse · indias · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —